期刊文献+

盐酸奥昔布宁醇脂质体凝胶的制备及质量评价 被引量:1

Preparation and Quality Evaluation of Oxybutynin Hydrochloride Ethosomal Gel
下载PDF
导出
摘要 目的 制备盐酸奥昔布宁醇脂质体凝胶剂,并评价体外经皮渗透性、pH、外观形态等方面的质量.方法 以羟丙基纤维素(HPC)为基质制备OXB醇脂质体凝胶;采用Franz透皮扩散实验仪考察醇脂质体凝胶和普通凝胶的经皮渗透性;高效液相色谱法测定其中主药含量,并评价其质量.结果 醇脂质体凝胶(4% OXB)的累积渗透率是普通凝胶(10% OXB)的3.9倍.盐酸奥昔布宁线性范围为10 ~1 000 μg/mL,平均回收率为99.58%.结论 制备的醇脂质体凝胶经皮渗透性高,质量稳定可控. Objective To prepare oxybutynin(OXB) hydrochloride ethosomal gel and to perform the quality evaluation on the transdermal penetrability in vitro,pH and appearance shape.Methods Hydroxypropyl cellulose (HPC) was used as the base material to prepare OXB ethosomal gel; the Franz in vitro transdermal diffusion test was adopted to investigate the in vitro transdermal penetrability of the ethosomal gel and the common gel; the content of OXB hydrochloride was determined by high performance liquid chromatography (HPLC),and its quality was evaluated.Results The cumulative permeation rate of the ethosomal gel(4% OXB) was 3.9 times of the common gel(10% OXB).The linear range of OXB hydrochloride was 10-1 000 μg/mL,the average recovery rate was 99.58%.Conclusion The prepared OXB ethosomal gel has the high transdermal penetrability with stable and controllable quality.
出处 《中国药业》 CAS 2014年第5期42-44,共3页 China Pharmaceuticals
关键词 盐酸奥昔布宁 醇脂质体凝胶剂 经皮渗透性 质量评价 oxybutynin hydrochloride ethosomal gel transdermal penetrability quality evaluation
  • 相关文献

参考文献3

二级参考文献31

  • 1吕惠兰,温清,王本杰,郭瑞臣.健康志愿者盐酸奥昔布宁缓释制剂与普通制剂药代动力学及生物等效性研究[J].山东大学学报(医学版),2005,43(7):657-660. 被引量:3
  • 2Touitou E. Compositions for applying active substances to or through the skin : US,5540934 [ P]. 1996-07-30.
  • 3Jain S, Tiwary AK, Sapra B, et al. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine [ J ]. AAPS PharmSciTech, 2007,8 ( 4 ) : 1 - 9.
  • 4Elsayed MMA, Abdallah OY, Naggar VF, et al. Deformable liposomes and ethosomes : mechanism of enhanced skin delivery [ J ]. lnt J Pharm,2006,322( 1 ) :60 -66.
  • 5Lopez-pinto JM, Gonzalez-Rodriguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes [ J ]. Int J Pharm,2005,298 ( 1 ) : 1 - 12.
  • 6Touitou E,Dayan N,Bergelson L,et al. Ethosomes novel vesicular carriers for enhanced delivery :characterization and skin penetration properties [ J ]. J Control Release,2000,65 ( 3 ) :403 - 418.
  • 7Eeva Lukkari, Kari Aranko, Auni Juhakoski, et al. Effect of Time Interval between Food and Drug Ingestion on the Absorption of Oxybutynin from a Controlled-release Tablet[J]. Pharmacology & Toxlcology .1997,81:31
  • 8Appell RA, Sand P, Dmochowski R et al: Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT study[J]. Mayo Clin Proc 2001,76:358
  • 9Noronha-Blob L and Kachur. Enantiomers of oxybutynin:In vitro pharmacological characterization at M1,M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contration,mydriasis and salivary secretion in guinea pigs[J]. Pharmacol Exp. Ther.1
  • 10Fredericks CM, Anderson GF & Kreulen DL. A Study of the Anticholinergic and Antispasmodic Activity of Oxybutynin (Ditropan(R)) on Rabbit Detrusor[J]. Invest Urol 1975,12:317

共引文献12

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部